Craig Adam R

Craig Adam R is listed in filings as Executive Chairman at X4 Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Oct 31, 2025, including purchase activity. Recent filings connect the profile to X4 Pharmaceuticals, Inc. (XFOR). The current snapshot covers public activity from Aug 14, 2025 to Oct 31, 2025. Reported amounts are shown as $3.3M to $1.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.